Welcome to Molecular Psychiatry

Molecular Psychiatry publishes definitive, high-impact work that elucidates key issues in psychiatry and related fields. The emphasis is on bringing together in one journal the best pre-clinical and clinical research, including research at the cellular, molecular, integrative, epidemiological, translational, clinical, imaging, psychopharmacology, and treatment outcome levels. Cutting-edge articles are highly cited in the fields of psychiatry, psychology, neuroscience, biochemistry & molecular biology.

About the cover Free online issue

Volume 13, No 12
December 2008

ISSN: 1359-4184
EISSN: 1476-5578

Impact Factor 10.900*
2/94 Psychiatry
7/211 Neuroscience
13/263 Biochemistry & Molecular Biology

Editor:
Julio Licinio, MD

*2007 Journal Citation Report (Thomson Reuters, 2008)

NEWS

There are, to date, no objective clinical laboratory blood tests for mood disorders. Current reliance on patients self-reporting symptom severity, and on the impressions of clinicians, is a rate limiting step in effective treatment and new drug development. These studies suggest blood biomarkers may offer an unexpectedly informative window into brain functioning and disease state.

One in eight US adults smoke a pack of cigarettes a day and most of the risk of habitual heavy smoking (nicotine addiction) is genetic. This paper studied DNA samples from 14,000 people and showed the most important genetic predictors of nicotine addiction are variants in genes that produce the brain proteins to which nicotine binds.

Extra navigation

4 December 2008

naturejobs

natureproducts


ADVERTISEMENT